Firocoxib Butene Derivative - Request Quote
Firocoxib Butene Derivative
| SZ CAT No: | SZ-F055006 |
| CAS No | NA |
| Mol.F. | C17H20O5S |
| Mol.Wt. |
336.4 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Hazard Statement:
Usage Note:
Firocoxib Butene Derivative is chemically 3-(But-3-en-1yloxy)-5,5dimethyl-4-[4(methylsulfonyl)phenyl]furan-2(5H)one. Firocoxib Butene Derivative is supplied with detailed characterization data compliant with regulatory guideline. Firocoxib Butene Derivative can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Firocoxib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Firocoxib Butene Derivative
Purchase Firocoxib Butene Derivative
Firocoxib Butene Derivative suppliers
Firocoxib Butene Derivative manufacturers
Firocoxib Butene Derivative price
Order Firocoxib Butene Derivative
Enquire Firocoxib Butene Derivative
Firocoxib Butene Derivative cost
Firocoxib Butene Derivative Supplier
Firocoxib Butene Derivative Distributor
Firocoxib Butene Derivative for Method Validation
Firocoxib Reference Standard
Firocoxib Butene Derivative for ANDA Filing
Firocoxib Butene Derivative for Forced Degradation Studies
Firocoxib Butene Derivative Identification Standards
Firocoxib Butene Derivative for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


